SEC Filing Update: #ROIV Roivant Sciences Ltd. : $36.28

Sector: Healthcare | YTD: 🔼+ 65.51% The SEC disclosed Today (13-AUG-2026) that MORGAN STANLEY has DECREASED #ROIV Shares by -4.46% 🔴 * Previous Holdings: 42.59M Shares * Current Holdings: 40.69M Shares * Decrease -1.90M * Decreased (%)-4.46% * Ownership: 5.7% https://www.thinksabio.com/reports/isr/ROIV Institutional ownership in #ROIV has been steadily rising over the past 3 quarters in Shares: Q3 2025: 501.60M Q4 2025: 508.80M Q1 2026: 530.04M The quarterly average prices of #ROIV: Q2 2025: $10.83 Q3 2025: $12.38 Q4 2025: $19.70 Q1 2026: $25.70